Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
R3H domain-containing protein 2 (R3HDM2) is a human protein encoded by the R3HDM2 gene, containing a conserved R3H domain—a sequence motif believed to mediate nucleic acid (including RNA and single-stranded DNA) binding, typically located in the cell nucleus[2][6][9]. Its biological role involves RNA binding, but it is not known to function as a receptor, enzyme, transporter, or established therapeutic target. R3HDM2 does not have any well-established disease associations, drug interactions, or known roles in cell signaling, and appears instead to participate in RNA metabolism or regulation[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on R3H domain-containing protein 2 (R3HDM2).